Cargando…
A Single Injection of an Optimized Adeno-Associated Viral Vector into Cerebrospinal Fluid Corrects Neurological Disease in a Murine Model of GM1 Gangliosidosis
GM1 gangliosidosis is a rare neurodegenerative lysosomal storage disease caused by loss-of-function mutations in the gene encoding beta-galactosidase (β-gal). There are no approved treatments for GM1 gangliosidosis. Previous studies in animal models have demonstrated that adeno-associated viral (AAV...
Autores principales: | Hinderer, Christian, Nosratbakhsh, Brenden, Katz, Nathan, Wilson, James M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698982/ https://www.ncbi.nlm.nih.gov/pubmed/33045869 http://dx.doi.org/10.1089/hum.2018.206 |
Ejemplares similares
-
Genetics and Therapies for GM2 Gangliosidosis
por: Cachón-González, María Begoña, et al.
Publicado: (2018) -
GM1 Gangliosidosis: Mechanisms and Management
por: Rha, Allisandra K, et al.
Publicado: (2021) -
Efficacy of Adeno-Associated Virus Serotype 9-Mediated Gene Therapy for AB-Variant GM2 Gangliosidosis
por: Vyas, Meera, et al.
Publicado: (2023) -
Characterization of glycan substrates accumulating in GM1 Gangliosidosis
por: Lawrence, Roger, et al.
Publicado: (2019) -
GM1 Gangliosidosis—A Mini-Review
por: Nicoli, Elena-Raluca, et al.
Publicado: (2021)